These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18626286)

  • 21. An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
    Conway CR; Chibnall JT; Nelson LA; McGuire JM; Abraham PF; Baram VY; Grossberg GT; Carroll BJ
    J Clin Psychopharmacol; 2006 Feb; 26(1):95-7. PubMed ID: 16415718
    [No Abstract]   [Full Text] [Related]  

  • 22. Valproate and neuroleptic medication.
    Reutens S; Castle D
    Br J Psychiatry; 1997 May; 170():484-5. PubMed ID: 9307707
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone as an adjunct to valproic acid.
    Waring EW; Dewan VK; Cohen D; Grewal R
    Can J Psychiatry; 1999 Mar; 44(2):189. PubMed ID: 10097843
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy.
    Cansu A; Yesilkaya E; Serdaroglu A; Camurdan O; Hirfanoglu TL; Karaoglu A; Bideci A; Cinaz P
    Endocr Res; 2012; 37(4):163-74. PubMed ID: 22630163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emerging role of valproate in bipolar disorder and other psychiatric disorders.
    Guay DR
    Pharmacotherapy; 1995; 15(5):631-47. PubMed ID: 8570437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
    Emrich HM; Altmann H; Dose M; von Zerssen D
    Pharmacol Biochem Behav; 1983 Aug; 19(2):369-72. PubMed ID: 6415677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and excretion of mood stabilizers and new anticonvulsants.
    Ketter TA; Frye MA; Corá-Locatelli G; Kimbrell TA; Post RM
    Cell Mol Neurobiol; 1999 Aug; 19(4):511-32. PubMed ID: 10379423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotoxicity associated with free valproic acid.
    Mayerhoff DI; Nurenberg J; Shah S; Schleifer SJ
    Am J Psychiatry; 2005 Apr; 162(4):810. PubMed ID: 15800163
    [No Abstract]   [Full Text] [Related]  

  • 31. Clozapine-Valproate Adverse Drug Reactions and the Need for a Clozapine Rechallenge Case File.
    Kanofsky JD; Woesner ME
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102977
    [No Abstract]   [Full Text] [Related]  

  • 32. Retinal ganglion cell toxicity due to oxcarbazepine and valproic acid treatment in rat.
    Aktaş Z; Cansu A; Erdoğan D; Take G; Goktas G; Ozdek S; Serdaroglu A
    Seizure; 2009 Jul; 18(6):396-9. PubMed ID: 19329338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders.
    Lopez-Larson M; Frazier JA
    Harv Rev Psychiatry; 2006; 14(6):285-304. PubMed ID: 17162653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study.
    Eyer F; Schreckenberg M; Hecht D; Adorjan K; Schuster T; Felgenhauer N; Pfab R; Strubel T; Zilker T
    Alcohol Alcohol; 2011; 46(2):177-84. PubMed ID: 21339186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive review of the psychiatric uses of valproate.
    Davis LL; Ryan W; Adinoff B; Petty F
    J Clin Psychopharmacol; 2000 Feb; 20(1 Suppl 1):1S-17S. PubMed ID: 10646685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of patients hospitalized with the diagnosis of schizoaffective disorder.
    Grieger TA; Benedek DM; Flynn J
    J Clin Psychiatry; 2001 Jan; 62(1):59-60. PubMed ID: 11235933
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproate and other anticonvulsants for psychiatric disorders.
    Med Lett Drugs Ther; 2000 Dec; 42(1094):114-5. PubMed ID: 11114842
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders].
    Mosolov SN; Kostiukova EG; Ladyzhenskiĭ MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):36-41. PubMed ID: 20037568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.